Steward Partners Investment Advisory, LLC Atara Biotherapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$10.89 - $16.79 $5,445 - $8,395	-500 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$19.05 - $41.04 $9,525 - $20,520	500 New	500 $10,000
Q4 2018 Jan 15, 2019	SELL	$30.9 - $42.97 $30,900 - $42,970	-1,000 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$13.2 - $18.1 $13,200 - $18,100	1,000	1,000 $18,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.